Introduction Endothelial dysfunction is associated with a host of disease states including cardiovascular disease, diabetes, chronic kidney disease, and atherosclerosis. Previous research by our laboratory has shown that vasomotor function, and more specifically endothelium-dependent vasorelaxation responses, differ across large arteries from mice with distinct genetic backgrounds. However, it is unclear how much of the observed variation in endothelium-dependent vasorelaxation is due to nitric oxide (NO) mediated pathways. Objective The purpose of this study was to test the hypothesis that strain-dependent vasorelaxation differences were primarily the result of differences in reliance on NO-mediated pathways. Methods Vasomotor function was assessed in thoracic aorta, abdominal aorta, carotid arteries, and femoral arteries from four inbred strains (SJL/J (SJL), DBA/2J (DBA), NZW/LacJ (NZW) and C57BL/6J (B6)) of mice. Strains were chosen based on previously documented vasomotor variation and susceptibility to clinically significant pathologies. Arteries were dissected, cut into 2mm segments, and mounted in a wire myograph system. Arterial segments were stretched to a resting tension equivalent to a pressure of 90mmHg for all strains based on a passive stretch and relaxation tension-force assessment. Increasing concentrations of the endothelium-dependent vasodilator acetylcholine (ACh, 1x10-9 – 1x10-5M) and endothelium-independent vasodilator sodium nitroprusside (SNP, 1x10-9 – 1x10-5M) were used to assess vasorelaxation responses. To assess reliance on NO, vasorelaxation responses to Ach and SNP were assessed in the presence of a nitric oxide synthase inhibitor (NOS). One arterial segment from each group was treated with the NOS inhibitor N omega-Nitro-L-arginine methyl ester hydrochloride (L-NAME: 10x4 M) for thirty minutes. Results Two way ANOVA revealed a significant main effect of strain in vasorelaxation responses to ACh for all arteries tested (P <.0001) and no significant differences in response to SNP. Maximal relaxation responses to ACh were significantly inhibited in all arterial segments treated with L-NAME, while no differences were detected for L-NAME treated vessels in response to SNP. These findings indicate that large arteries have a strong dependence on NO-mediated, endothelium-dependent pathways to maintain vascular regulation. Furthermore, strain-dependent vasorelaxation differences were abolished in the presence of L-NAME indicating that strain differences were NO-dependent. Conclusion These findings indicate a strong influence of genetic background on endothelial function and suggest that these differences are primarily due to strain related reliance on NO for endothelium-dependent vasodilation.
Read full abstract